| Molecule Name | Therapeutic Area | Investigational Indication | Modality | Phase |
|---|---|---|---|---|
|
BLINCYTO®
(blinatumomab)
|
Hematology / Oncology | Acute Lymphoblastic Leukemia | BiTE® Molecule | 3 |
| Inflammation | Systemic Lupus Erythematosus with Nephritis | BiTE® Molecule | 2 | |
| Inflammation | Refractory Rheumatoid Arthritis | BiTE® Molecule | 1 |
Ripe Downtown
Ripe Downtown